Liminatus Pharma, Inc. (LIMN) — Institutional Holders, Q2 2026

35 institutional investment managers reported a LIMN position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $193.0K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

LIMN in Q2 2026: what funds did

Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.

New positions

5

Added to

1

Trimmed

11

Sold out

4

Biggest buyers

  1. XTX Topco LtdNew · +221,839 sh+$16.7K
  2. GOLDMAN SACHS GROUPNew · +40,220 sh+$3.0K
  3. StoneX GroupNew · +26,058 sh+$2.0K
  4. SUSQUEHANNA INTERNATIONAL GROUP, LLPNew · +17,562 sh+$1.3K
  5. BARCLAYS PLCNew · +4,290 sh+$323.00

Biggest sellers

  1. JANE STREET GROUPTrimmed · -71,318 sh-$5.4K
  2. WOLVERINE ASSET MANAGEMENTTrimmed · -25,397 sh-$1.9K
  3. PERISCOPE CAPITALTrimmed · -17,500 sh-$1.3K
  4. GTS SECURITIESTrimmed · -100 sh-$8.00
  5. Clear Street GroupSold out · -100 sh-$8.00

LIMN 13F holders ranked 1–35 of 35

Institutional investors reporting a position in Liminatus Pharma, Inc. on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
Cygnus Capital Advisors#1 · 329,333 sh$36.0K-5.9%
XTX Topco Ltd#2 · 221,839 sh$24.5KNew
ARISTEIA CAPITAL, L.L.C.#3 · 319,510 sh$16.3K0.0%
GEODE CAPITAL MANAGEMENT#4 · 138,418 sh$15.3K+17.5%
LINDEN ADVISORS#5 · 268,199 sh$13.7K0.0%
Saba Capital Management, L.P.#6 · 233,761 sh$11.9K0.0%
MOORE CAPITAL MANAGEMENT#7 · 125,000 sh$9.4K0.0%
MMCAP International SPC#8 · 111,745 sh$8.4K0.0%
Polar Asset Management Partners#9 · 122,688 sh$6.3K0.0%
CITADEL ADVISORS#10 · 56,089 sh$6.2K-91.7%
VANGUARD CAPITAL MANAGEMENT#11 · 50,440 sh$5.5K0.0%
GOLDMAN SACHS GROUP#12 · 40,220 sh$4.4KNew
StoneX Group#13 · 26,058 sh$3.9KNew
D. E. Shaw#14 · 83,353 sh$2.9K0.0%
TORONTO DOMINION BANK#15 · 35,100 sh$2.6K0.0%
VANGUARD FIDUCIARY#16 · 22,984 sh$2.5K0.0%
LMR Partners LLP#17 · 29,961 sh$2.2K0.0%
UBS Group AG#18 · 21,237 sh$2.2K-64.1%
STATE STREET#19 · 19,000 sh$2.1K0.0%
Blue Owl Capital#20 · 50,000 sh$2.0K0.0%
PERISCOPE CAPITAL#21 · 30,000 sh$2.0K-36.8%
JANE STREET GROUP#22 · 24,274 sh$1.8K-74.6%
Limestone Investment Advisors#23 · 22,562 sh$1.7K0.0%
GTS SECURITIES#24 · 20,929 sh$1.6K-0.5%
Vanguard Personalized Indexing Management#25 · 13,148 sh$1.5K-62.1%
SUSQUEHANNA INTERNATIONAL GROUP, LLP#26 · 17,562 sh$1.3KNew
WOLVERINE ASSET MANAGEMENT#27 · 13,976 sh$1.0K-64.5%
FLOW TRADERS U.S.#28 · 13,110 sh$1.0K0.0%
Virtu Financial#29 · 10,805 sh$1.0K-60.7%
Tower Research Capital (TRC)#30 · 7,093 sh$783.00-6.3%
BARCLAYS PLC#31 · 4,290 sh$474.00New
DUPONT CAPITAL MANAGEMENT#32 · 6,250 sh$318.000.0%
HGC Investment Management#33 · 1,250 sh$94.000.0%
BlackRock#34 · 313 sh$35.00-97.6%
Arena Capital Advisors, - CA#35 · 29,166 sh—0.0%

Funds that sold out of LIMN in Q2 2026 (4)

Held LIMN at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.

Institutions that held LIMN in Q1 2026 and reported no position in Q2 2026.
InstitutionValue in Q1 2026
TWO SIGMA SECURITIES22,039 sh$3.8K
CITIGROUP6,769 sh$1.2K
Clear Street Group100 sh$4.00
Farther Finance Advisors14 sh$2.00

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.